Company Filing History:
7 out of 1,274 
6 out of 4,447 
1 out of 2,104 
Years Active: 2009-2024
Title: Innovations and Contributions of Brian Arthur Kuhlman
Introduction
Brian Arthur Kuhlman is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the development of bispecific antibodies. With a total of 8 patents to his name, Kuhlman's work has advanced the understanding and application of antibody engineering.
Latest Patents
Kuhlman's latest patents include innovative methods and processes related to IgG bispecific antibodies. One of his patents, titled "IgG bispecific antibodies and processes for preparation," provides fully IgG bi-specific antibodies that comprise designed residues in the interface of the heavy chain-heavy chain (C3/C3) domains. This invention also details processes for preparing these antibodies, along with nucleic acids, vectors, and host cells encoding the same. Another significant patent is "Methods for producing fabs and IgG bispecific antibodies," which outlines methods for producing Fabs and IgG bispecific antibodies by expressing nucleic acids that encode designed residues in the CH1/CL interface. This patent also includes Fabs and IgG bispecific antibodies produced according to the provided methods.
Career Highlights
Throughout his career, Kuhlman has worked with prestigious organizations, including the University of North Carolina at Chapel Hill and Eli Lilly and Company. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kuhlman has collaborated with notable colleagues such as Stephen John Demarest and Xiufeng Wu. These partnerships have further enriched his research and innovation in antibody engineering.
Conclusion
Brian Arthur Kuhlman is a distinguished inventor whose work in the field of biochemistry has led to significant advancements in antibody technology. His contributions continue to impact the scientific community and pave the way for future innovations.